Passage Bio, Inc. (PASG) Tops Q2 EPS by 3c
Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Passage Bio, Inc. (NASDAQ: PASG) reported Q2 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.